4.5 Review

Bacterial vaginosis: an update on diagnosis and treatment

Journal

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 7, Issue 9, Pages 1109-1124

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERI.09.87

Keywords

bacterial vaginosis; diagnosis; therapy; vaginal microflora; vaginitis

Ask authors/readers for more resources

Bacterial vaginosis is the most common cause of vaginal complaints. Bacterial vaginosis is further associated with a sizeable burden of infectious complications. Diagnosis relies on standardized clinical criteria or on scoring bacterial cell morphotypes on a Gram-stained vaginal smear. A few point-of-care tests have not gained footage in clinical practice, but molecular diagnosis is now pending. Treatment remains cumbersome and clinicians are currently rather poorly armed to treat bacterial vaginosis in the long run. As an adjuvant to standard treatment with antibiotics, alternative treatments with antiseptics and disinfectants, vaginal-acidifying and -buffering agents, and probiotics hold some promise for long-term prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Infectious Diseases

The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment: 2018 update

Hans Verstraelen, Alexander Swidsinski

CURRENT OPINION IN INFECTIOUS DISEASES (2019)

Letter Obstetrics & Gynecology

Bacterial vaginosis and the risk of human papillomavirus and cervical cancer REPLY

Nele Brusselaers, Hans Verstraelen

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)

Article Gastroenterology & Hepatology

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis

Alasdair J. Scott, James L. Alexander, Claire A. Merrifield, David Cunningham, Christian Jobin, Robert Brown, John Alverdy, Stephen J. O'Keefe, H. Rex Gaskins, Julian Teare, Jun Yu, David J. Hughes, Hans Verstraelen, Jeremy Burton, Paul W. O'Toole, Daniel W. Rosenberg, Julian R. Marchesi, James M. Kinross

Review Obstetrics & Gynecology

The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis

J. Norenhag, J. Du, M. Olovsson, H. Verstraelen, L. Engstrand, N. Brusselaers

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Editorial Material Oncology

Of microbes and women: BRCA1, vaginal microbiota, and ovarian cancer

Hans Verstraelen

LANCET ONCOLOGY (2019)

Letter Obstetrics & Gynecology

Dyspareunia in Zoon's vulvitis

Hans Verstraelen

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Allergy

A systematic review of allergic and irritative contact dermatitis of the vulva: The most important allergens/irritants and the role of patch testing

Sander Vandeweege, Britt Debaene, Hilde Lapeere, Hans Verstraelen

Summary: This study reviewed the literature on vulvar allergic contact dermatitis (vACD) and irritative contact dermatitis (vICD), providing a comprehensive reference list of potential vulvar allergens and irritants, and emphasizing the importance of patch testing for identifying causal allergens. Multiple allergens were identified, but not all positive reactions were relevant to the disease. Additional testing methods and late readings should be considered in standard practice. Limited information was found on irritants, highlighting the need for further research.

CONTACT DERMATITIS (2023)

Review Public, Environmental & Occupational Health

Scoping review of the association between bacterial vaginosis and emotional, sexual and social health

Judith Brusselmans, An De Sutter, Brecht Devleesschauwer, Hans Verstraelen, Piet Cools

Summary: This review examines the association between symptomatic bacterial vaginosis (BV) and the emotional, sexual, and social health of women. The results suggest that symptomatic BV may have an impact on the emotional, sexual, and social well-being of women, but more evidence is needed to determine the extent of this association.

BMC WOMENS HEALTH (2023)

Article Medicine, General & Internal

GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol

Glenn Vergauwen, Piet Cools, Hannelore Denys, Tom Fiers, Koen Van de Vijver, Liv Veldeman, Hans Verstraelen

Summary: Breast cancer is the most common cancer type in women worldwide. Endocrine therapy, which involves the use of selective estrogen receptor modulators or aromatase inhibitors, is crucial in the treatment of breast cancer. However, a common side effect of endocrine therapy is vulvovaginal atrophy, which negatively impacts patients' physical and psychological well-being.

BMJ OPEN (2023)

Review Obstetrics & Gynecology

The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders

Francesco De Seta, Risa Lonnee-Hoffmann, Giuseppina Campisciano, Manola Comar, Hans Verstraelen, Pedro Vieira-Baptista, Gary Ventolini, Ahinoam Lev-Sagie

Summary: The vaginal microbiome plays a crucial role in various urogenital disorders, including vulvovaginal candidiasis, urinary tract infections, and sexually transmitted infections. Imbalances in the vaginal microbiome increase the risk of infection. Therefore, understanding and controlling the balance of the vaginal microbiome is essential for the prevention and treatment of these diseases.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Review Obstetrics & Gynecology

The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions

Ahinoam Lev-Sagie, Francesco De Seta, Hans Verstraelen, Gary Ventolini, Risa Lonnee-Hoffmann, Pedro Vieira-Baptista

Summary: This series of articles aims to summarize recent findings on the vaginal bacterial microbiota and its relevance to clinicians specializing in vulvovaginal disorders. The second article focuses on vaginal dysbiotic conditions, including bacterial vaginosis and other conditions associated with lactobacilli depletion. The heterogeneity and diversity within the genus Gardnerella may impact the progression of bacterial vaginosis.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Review Obstetrics & Gynecology

The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers

Gary Ventolini, Pedro Vieira-Baptista, Francesco De Seta, Hans Verstraelen, Risa Lonnee-Hoffmann, Ahinoam Lev-Sagie

Summary: This article summarizes recent findings and understanding of the vaginal bacterial microbiota, particularly in relation to vulvovaginal disorders. The study highlights the association between altered vaginal microbiota and negative pregnancy outcomes, as well as gynecologic malignancies.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Review Obstetrics & Gynecology

The Vaginal Microbiome: I. Research Development, Lexicon, Defining Normal and the Dynamics Throughout Women's Lives

Hans Verstraelen, Pedro Vieira-Baptista, Francesco De Seta, Gary Ventolini, Risa Lonnee-Hoffmann, Ahinoam Lev-Sagie

Summary: This series of articles aims to summarize the current findings and understanding of the vaginal bacterial microbiota, with a focus on clinicians specializing in vulvovaginal disorders. Molecular techniques have advanced our understanding of vaginal health and the interactions between microorganisms inhabiting the vagina. The clinical implications of microbial community sequencing are still being determined.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Review Obstetrics & Gynecology

The Vaginal Microbiome: V. TherapeuticModalities of Vaginal Microbiome Engineering and Research Challenges

Pedro Vieira-Baptista, Francesco De Seta, Hans Verstraelen, Gary Ventolini, Risa Lonnee-Hoffmann, Ahinoam Lev-Sagie

Summary: This series of articles aims to summarize the recent findings and understanding of the vaginal microbiome, mainly for clinicians specializing in vulvovaginal disorders. The available approaches for treating vaginitis or modulating the vaginal microbiome are often insufficient, and this series discusses new and alternative therapeutic modalities, as well as the challenges facing microbiome research.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Article Psychology, Clinical

Ten years of fertility treatment experience and reproductive options in transgender men

Isabelle Stuyver, Sara Somers, Veerle Provoost, Katrien Wierckx, Hans Verstraelen, Elia Wyverkens, Lien Van Glabeke, Guy T'Sjoen, Ann Buysse, Guido Pennings, Petra De Sutter

Summary: This study examined the experiences of transgender men and their cisgender female partners who requested donor conception for having children. It found that most couples intended to disclose the use of donor sperm to their future child and saw donor conception as the preferred route to become parents. Transgender individuals should be counseled about all reproductive options to make informed decisions.

INTERNATIONAL JOURNAL OF TRANSGENDER HEALTH (2021)

No Data Available